BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Strazzabosco M, Fabris L, Spirli C. Pathophysiology of cholangiopathies. J Clin Gastroenterol 2005;39:S90-S102. [PMID: 15758666 DOI: 10.1097/01.mcg.0000155549.29643.ad] [Cited by in Crossref: 118] [Cited by in F6Publishing: 109] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Geier A, Fickert P, Trauner M. Mechanisms of Disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Rev Gastroenterol Hepatol 2006;3:574-85. [DOI: 10.1038/ncpgasthep0602] [Cited by in Crossref: 132] [Cited by in F6Publishing: 111] [Article Influence: 8.3] [Reference Citation Analysis]
2 Perino A, Demagny H, Velazquez-Villegas L, Schoonjans K. Molecular Physiology of Bile Acid Signaling in Health, Disease, and Aging. Physiol Rev 2021;101:683-731. [PMID: 32790577 DOI: 10.1152/physrev.00049.2019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
3 Spirli C, Strazzabosco M. Vascular endothelial growth factors in progenitor cells mediated liver repair. Hepatobiliary Surg Nutr 2013;2:65-7. [PMID: 24570918 DOI: 10.3978/j.issn.2304-3881.2012.12.05] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
4 Yang L, Li LC, Lamaoqiezhong, Wang X, Wang WH, Wang YC, Xu CR. The contributions of mesoderm-derived cells in liver development. Semin Cell Dev Biol 2019;92:63-76. [PMID: 30193996 DOI: 10.1016/j.semcdb.2018.09.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Glaser S, Wang M, Ueno Y, Venter J, Wang K, Chen H, Alpini G, Holterman A. Differential transcriptional characteristics of small and large biliary epithelial cells derived from small and large bile ducts. Am J Physiol Gastrointest Liver Physiol 2010;299:G769-77. [PMID: 20576918 DOI: 10.1152/ajpgi.00237.2010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
6 Aksu B, Umit H, Kanter M, Guzel A, Inan M, Civelek S, Aktas C, Uzun H. Effects of sphingosylphosphorylcholine against cholestatic oxidative stress and liver damage in the common bile duct ligated rats. Journal of Pediatric Surgery 2009;44:702-10. [DOI: 10.1016/j.jpedsurg.2008.09.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
7 Fiorotto R, Spirlì C, Fabris L, Cadamuro M, Okolicsanyi L, Strazzabosco M. Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. Gastroenterology 2007;133:1603-13. [PMID: 17983806 DOI: 10.1053/j.gastro.2007.08.071] [Cited by in Crossref: 89] [Cited by in F6Publishing: 79] [Article Influence: 5.9] [Reference Citation Analysis]
8 Dianat N, Weber A, Dubart-Kupperschmitt A. [Human pluripotent stem cells and liver disorders]. Biol Aujourdhui 2016;210:19-26. [PMID: 27286577 DOI: 10.1051/jbio/2016006] [Reference Citation Analysis]
9 Pass AK, McLin VA, Rushton JR, Kearney DL, Hastings CA, Margolin JF. Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature. J Pediatr Hematol Oncol. 2008;30:976-980. [PMID: 19131796 DOI: 10.1097/mph.0b013e31818b37c4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
10 Strazzabosco M, Fiorotto R, Cadamuro M, Spirli C, Mariotti V, Kaffe E, Scirpo R, Fabris L. Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium. Biochim Biophys Acta Mol Basis Dis 2018;1864:1374-9. [PMID: 28754453 DOI: 10.1016/j.bbadis.2017.07.023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
11 Tietz PS, Larusso NF. Cholangiocyte biology. Curr Opin Gastroenterol 2006;22:279-87. [PMID: 16550043 DOI: 10.1097/01.mog.0000218965.78558.bc] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
12 Wasuwanich P, Karnsakul W. Cystic fibrosis-associated liver disease in children.Minerva Pediatr. 2020;72:440-447. [PMID: 32418413 DOI: 10.23736/S0026-4946.20.05895-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Karaman A, Iraz M, Kirimlioglu H, Karadag N, Tas E, Fadillioglu E. Hepatic damage in biliary-obstructed rats is ameliorated by leflunomide treatment. Pediatr Surg Int 2006;22:701-8. [DOI: 10.1007/s00383-006-1744-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
14 Fiorotto R, Strazzabosco M. Cystic Fibrosis-Related Liver Diseases: New Paradigm for Treatment Based on Pathophysiology. Clin Liver Dis (Hoboken) 2016;8:113-6. [PMID: 31041076 DOI: 10.1002/cld.583] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
15 Fabris L, Strazzabosco M. Epithelial-mesenchymal interactions in biliary diseases. Semin Liver Dis 2011;31:11-32. [PMID: 21344348 DOI: 10.1055/s-0031-1272832] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
16 Oguz S, Kanter M, Erboga M, Ibis C. Protective effect of Urtica dioica on liver damage induced by biliary obstruction in rats. Toxicol Ind Health 2013;29:838-45. [PMID: 22585933 DOI: 10.1177/0748233712445045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
17 El-Araby HA, Saber MA, Radwan NM, Taie DM, Adawy NM, Sira AM. Temporal histopathological changes in biliary atresia: A perspective for rapid fibrosis progression. Ann Hepatol 2021;21:100263. [PMID: 33007429 DOI: 10.1016/j.aohep.2020.09.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Fouassier L, Fiorotto R. Ezrin finds its groove in cholangiocytes. Hepatology 2015;61:1467-70. [PMID: 25545157 DOI: 10.1002/hep.27675] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
19 Valamparampil JJ, Gupte GL. Cystic fibrosis associated liver disease in children. World J Hepatol 2021; 13(11): 1727-1742 [PMID: 34904041 DOI: 10.4254/wjh.v13.i11.1727] [Reference Citation Analysis]
20 Fabris L, Brivio S, Cadamuro M, Strazzabosco M. Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial Phenotype. Stem Cells Int 2016;2016:2953727. [PMID: 26880950 DOI: 10.1155/2016/2953727] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
21 Gong AY, Zhou R, Hu G, Liu J, Sosnowska D, Drescher KM, Dong H, Chen XM. Cryptosporidium parvum induces B7-H1 expression in cholangiocytes by down-regulating microRNA-513. J Infect Dis 2010;201:160-9. [PMID: 19916867 DOI: 10.1086/648589] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
22 Polidoro MA, Ferrari E, Marzorati S, Lleo A, Rasponi M. Experimental liver models: From cell culture techniques to microfluidic organs-on-chip. Liver Int 2021;41:1744-61. [PMID: 33966344 DOI: 10.1111/liv.14942] [Reference Citation Analysis]
23 Morell CM, Strazzabosco M. Notch signaling and new therapeutic options in liver disease. J Hepatol. 2014;60:885-890. [PMID: 24308992 DOI: 10.1016/j.jhep.2013.11.028] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 7.6] [Reference Citation Analysis]
24 Han Y, Glaser S, Meng F, Francis H, Marzioni M, McDaniel K, Alvaro D, Venter J, Carpino G, Onori P, Gaudio E, Alpini G, Franchitto A. Recent advances in the morphological and functional heterogeneity of the biliary epithelium. Exp Biol Med (Maywood). 2013;238:549-565. [PMID: 23856906 DOI: 10.1177/1535370213489926.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Fabris L, Spirli C, Cadamuro M, Fiorotto R, Strazzabosco M. Emerging concepts in biliary repair and fibrosis. Am J Physiol Gastrointest Liver Physiol 2017;313:G102-16. [PMID: 28526690 DOI: 10.1152/ajpgi.00452.2016] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 8.4] [Reference Citation Analysis]
26 Srivastava B, Gimson A. Hepatic changes in systemic infection. Best Pract Res Clin Gastroenterol 2013;27:485-95. [PMID: 24090937 DOI: 10.1016/j.bpg.2013.06.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
27 Fahmy SR, Mohamed AS, Hosney M, Issa HA, Hassanein SS, Soliman AM. Hepatotoxicity effect of short-term Bradykinin potentiating factor in cholestatic rats. Toxicology Letters 2019;301:73-8. [DOI: 10.1016/j.toxlet.2018.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
28 Aktas C, Kanter M, Erboga M, Mete R, Oran M. Melatonin attenuates oxidative stress, liver damage and hepatocyte apoptosis after bile-duct ligation in rats. Toxicol Ind Health 2014;30:835-44. [PMID: 23095487 DOI: 10.1177/0748233712464811] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
29 Aksu B, Umit H, Kanter M, Guzel A, Aktas C, Civelek S, Uzun H. Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats. Acta Histochemica 2010;112:259-69. [DOI: 10.1016/j.acthis.2008.12.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
30 Mattei P, von Allmen D, Piccoli D, Rand E. Relief of intractable pruritus in Alagille syndrome by partial external biliary diversion. J Pediatr Surg 2006;41:104-7; discussion 104-7. [PMID: 16410117 DOI: 10.1016/j.jpedsurg.2005.10.014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
31 Strazzabosco M. Foxa1 and Foxa2 regulate bile duct development in mice. J Hepatol. 2010;52:765-767. [PMID: 20347503 DOI: 10.1016/j.jhep.2009.12.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
32 Kanter M. Protective effect of quercetin on liver damage induced by biliary obstruction in rats. J Mol Hist 2010;41:395-402. [DOI: 10.1007/s10735-010-9301-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
33 Zhang X, Zong C, Zhang L, Garner E, Sugie S, Huang C, Wu W, Chang J, Sakurai T, Kato M, Ichihara S, Kumagai S, Ichihara G. Exposure of Mice to 1,2-Dichloropropane Induces CYP450-Dependent Proliferation and Apoptosis of Cholangiocytes. Toxicological Sciences 2018;162:559-69. [DOI: 10.1093/toxsci/kfx272] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
34 Morell CM, Fabris L, Strazzabosco M. Vascular biology of the biliary epithelium. J Gastroenterol Hepatol. 2013;28 Suppl 1:26-32. [PMID: 23855292 DOI: 10.1111/jgh.12022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
35 Claudel T, Zollner G, Wagner M, Trauner M. Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2011;1812:867-78. [DOI: 10.1016/j.bbadis.2010.12.021] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
36 Pinto C, Giordano DM, Maroni L, Marzioni M. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864:1270-8. [DOI: 10.1016/j.bbadis.2017.07.024] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
37 Chen L, Cai M, Zhang Q, Li Z, Qian Y, Bai H, Wei X, Shi B, Dong J. Activation of Interleukin-6/STAT3 in Rat Cholangiocyte Proliferation Induced by Lipopolysaccharide. Dig Dis Sci 2009;54:547-54. [DOI: 10.1007/s10620-008-0401-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
38 Yoo KS, Lim WT, Choi HS. Biology of Cholangiocytes: From Bench to Bedside. Gut Liver. 2016;10:687-698. [PMID: 27563020 DOI: 10.5009/gnl16033] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
39 Li Z, White P, Tuteja G, Rubins N, Sackett S, Kaestner KH. Foxa1 and Foxa2 regulate bile duct development in mice. J Clin Invest. 2009;119:1537-1545. [PMID: 19436110 DOI: 10.1172/jci38201] [Cited by in Crossref: 93] [Cited by in F6Publishing: 64] [Article Influence: 7.2] [Reference Citation Analysis]
40 Mariotti V, Strazzabosco M, Fabris L, Calvisi DF. Animal models of biliary injury and altered bile acid metabolism. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1254-1261. [PMID: 28709963 DOI: 10.1016/j.bbadis.2017.06.027] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 10.2] [Reference Citation Analysis]
41 Samant H, Manatsathit W, Dies D, Shokouh-Amiri H, Zibari G, Boktor M, Alexander JS. Cholestatic liver diseases: An era of emerging therapies. World J Clin Cases 2019; 7(13): 1571-1581 [PMID: 31367616 DOI: 10.12998/wjcc.v7.i13.1571] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Golbar HM, Izawa T, Yano R, Ichikawa C, Sawamoto O, Kuwamura M, Lamarre J, Yamate J. Immunohistochemical Characterization of Macrophages and Myofibroblasts in α-Naphthylisothiocyanate (ANIT)–Induced Bile Duct Injury and Subsequent Fibrogenesis in Rats. Toxicol Pathol 2011;39:795-808. [DOI: 10.1177/0192623311413790] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
43 Strnad P, Tacke F, Koch A, Trautwein C. Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14:55-66. [PMID: 27924081 DOI: 10.1038/nrgastro.2016.168] [Cited by in Crossref: 168] [Cited by in F6Publishing: 155] [Article Influence: 28.0] [Reference Citation Analysis]
44 Strazzabosco M, Somlo S. Polycystic liver diseases: congenital disorders of cholangiocyte signaling. Gastroenterology 2011;140:1855-9, 1859.e1. [PMID: 21515270 DOI: 10.1053/j.gastro.2011.04.030] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
45 Chen G, Zhang L, Chen L, Wang H, Zhang Y, Bie P. Role of Integrin αvβ6 in the Pathogenesis of Ischemia-Related Biliary Fibrosis After Liver Transplantation. Transplantation 2013;95:1092-9. [DOI: 10.1097/tp.0b013e3182884866] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
46 Priester S, Wise C, Glaser SS. Involvement of cholangiocyte proliferation in biliary fibrosis. World J Gastrointest Pathophysiol 2010; 1(2): 30-37 [PMID: 21607140 DOI: 10.4291/wjgp.v1.i2.30] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
47 Fuchs M, Sanyal AJ. Sepsis and cholestasis. Clin Liver Dis 2008;12:151-72, ix. [PMID: 18242502 DOI: 10.1016/j.cld.2007.11.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
48 Scirpo R, Fiorotto R, Villani A, Amenduni M, Spirli C, Strazzabosco M. Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium. Hepatology 2015;62:1551-62. [PMID: 26199136 DOI: 10.1002/hep.28000] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 9.6] [Reference Citation Analysis]
49 Iacob S, Cicinnati VR, Dechêne A, Lindemann M, Heinemann FM, Rebmann V, Ferencik S, Sotiropoulos GC, Popescu I, Horn PA, Gerken G, Paul A, Beckebaum S. Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation. Liver Int 2012;32:1253-61. [PMID: 22550960 DOI: 10.1111/j.1478-3231.2012.02810.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
50 Strazzabosco M, Fiorotto R, Melero S, Glaser S, Francis H, Spirli C, Alpini G. Differentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation. Hepatology 2009;50:244-52. [PMID: 19444869 DOI: 10.1002/hep.22926] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
51 Ayvaz S, Kanter M, Aksu B, Sahin SH, Uzun H, Erboga M, Pul M. The effects of hyperbaric oxygen application against cholestatic oxidative stress and hepatic damage after bile duct ligation in rats. J Surg Res 2013;183:146-55. [PMID: 23462455 DOI: 10.1016/j.jss.2012.12.036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
52 Newton JM, Aronsohn A, Jensen DM. Liver Dysfunction in Critically Ill Patients. In: Rajendram R, Preedy VR, Patel VB, editors. Diet and Nutrition in Critical Care. New York: Springer; 2015. pp. 35-48. [DOI: 10.1007/978-1-4614-7836-2_47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
53 Mizuguchi Y, Specht S, Isse K, Lunz JG, Demetris AJ. Biliary Epithelial Cells. In: Monga SPS, editor. Molecular Pathology of Liver Diseases. Boston: Springer US; 2011. pp. 27-51. [DOI: 10.1007/978-1-4419-7107-4_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
54 Glaser SS, Gaudio E, Alpini G. Vascular factors, angiogenesis and biliary tract disease. Curr Opin Gastroenterol. 2010;26:246-250. [PMID: 20061944 DOI: 10.1097/mog.0b013e3283369d19] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
55 Cadamuro M, Girardi N, Gores GJ, Strazzabosco M, Fabris L. The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases. Front Med (Lausanne) 2020;7:115. [PMID: 32373615 DOI: 10.3389/fmed.2020.00115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Fickert P, Stöger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH, Tsybrovskyy O, Jaeschke H, Zatloukal K, Denk H. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol. 2007;171:525-536. [PMID: 17600122 DOI: 10.2353/ajpath.2007.061133] [Cited by in Crossref: 214] [Cited by in F6Publishing: 202] [Article Influence: 14.3] [Reference Citation Analysis]
57 Wagner M, Zollner G, Trauner M. New molecular insights into the mechanisms of cholestasis. J Hepatol. 2009;51:565-580. [PMID: 19595470 DOI: 10.1016/j.jhep.2009.05.012] [Cited by in Crossref: 164] [Cited by in F6Publishing: 145] [Article Influence: 12.6] [Reference Citation Analysis]
58 Afroze SH, Munshi MK, Martínez AK, Uddin M, Gergely M, Szynkarski C, Guerrier M, Nizamutdinov D, Dostal D, Glaser S. Activation of the renin-angiotensin system stimulates biliary hyperplasia during cholestasis induced by extrahepatic bile duct ligation. Am J Physiol Gastrointest Liver Physiol 2015;308:G691-701. [PMID: 25678505 DOI: 10.1152/ajpgi.00116.2014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
59 Roma MG, Crocenzi FA, Sánchez Pozzi EA. Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects. Clin Sci (Lond) 2008;114:567-88. [PMID: 18377365 DOI: 10.1042/CS20070227] [Cited by in Crossref: 30] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
60 Peng J. The Pharmacological Targets and Clinical Evidence of Natural Products With Anti-hepatic Inflammatory Properties. Front Pharmacol 2018;9:455. [PMID: 29922155 DOI: 10.3389/fphar.2018.00455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
61 Fickert P, Thueringer A, Moustafa T, Silbert D, Gumhold J, Tsybrovskyy O, Lebofsky M, Jaeschke H, Denk H, Trauner M. The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice. Lab Invest. 2010;90:844-852. [PMID: 20368698 DOI: 10.1038/labinvest.2010.61] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
62 Gong AY, Zhou R, Hu G, Li X, Splinter PL, O'Hara SP, LaRusso NF, Soukup GA, Dong H, Chen XM. MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes. J Immunol 2009;182:1325-33. [PMID: 19155478 DOI: 10.4049/jimmunol.182.3.1325] [Cited by in Crossref: 137] [Cited by in F6Publishing: 147] [Article Influence: 10.5] [Reference Citation Analysis]
63 Kaffe E, Fiorotto R, Pellegrino F, Mariotti V, Amenduni M, Cadamuro M, Fabris L, Strazzabosco M, Spirli C. β-Catenin and interleukin-1β-dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis. Hepatology 2018;67:1903-19. [PMID: 29140564 DOI: 10.1002/hep.29652] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
64 Goree JR, Lavoie EG, Fausther M, Dranoff JA. Expression of mediators of purinergic signaling in human liver cell lines. Purinergic Signal 2014;10:631-8. [PMID: 25194703 DOI: 10.1007/s11302-014-9425-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
65 Gaudio E, Franchitto A, Pannarale L, Carpino G, Alpini G, Francis H, Glaser S, Alvaro D, Onori P. Cholangiocytes and blood supply. World J Gastroenterol 2006; 12(22): 3546-3552 [PMID: 16773711 DOI: 10.3748/wjg.v12.i22.3546] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
66 Fabris L, Cadamuro M, Guido M, Spirli C, Fiorotto R, Colledan M, Torre G, Alberti D, Sonzogni A, Okolicsanyi L. Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling. Am J Pathol. 2007;171:641-653. [PMID: 17600123 DOI: 10.2353/ajpath.2007.070073] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 5.9] [Reference Citation Analysis]
67 Spirli C, Okolicsanyi S, Fiorotto R, Fabris L, Cadamuro M, Lecchi S, Tian X, Somlo S, Strazzabosco M. Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice. Hepatology 2010;51:1778-88. [PMID: 20131403 DOI: 10.1002/hep.23511] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 5.2] [Reference Citation Analysis]
68 Tischendorf JJ, Geier A, Trautwein C. Current diagnosis and management of primary sclerosing cholangitis. Liver Transpl. 2008;14:735-746. [PMID: 18508363 DOI: 10.1002/lt.21456] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
69 Aronsohn A, Jensen D. Hepatobiliary manifestations of critically ill and postoperative patients. Clin Liver Dis 2011;15:183-97. [PMID: 21112000 DOI: 10.1016/j.cld.2010.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
70 Bakhit M, McCarty TR, Park S, Njei B, Cho M, Karagozian R, Liapakis A. Vanishing bile duct syndrome in Hodgkin’s lymphoma: A case report and literature review. World J Gastroenterol 2017; 23(2): 366-372 [PMID: 28127210 DOI: 10.3748/wjg.v23.i2.366] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
71 Arends B, Slump E, Spee B, Rothuizen J, Penning LC. Hepatocyte growth factor improves viability after H2O2-induced toxicity in bile duct epithelial cells. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2008;147:324-30. [DOI: 10.1016/j.cbpc.2007.12.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
72 Mariotti V, Cadamuro M, Spirli C, Fiorotto R, Strazzabosco M, Fabris L. Animal models of cholestasis: An update on inflammatory cholangiopathies. Biochim Biophys Acta Mol Basis Dis 2019;1865:954-64. [PMID: 30398152 DOI: 10.1016/j.bbadis.2018.07.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
73 Dolganiuc A. Role of lipid rafts in liver health and disease. World J Gastroenterol 2011; 17(20): 2520-2535 [PMID: 21633657 DOI: 10.3748/wjg.v17.i20.2520] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
74 Kim Y, Lee EJ, Jang HK, Kim CH, Kim DG, Han JH, Park SM. Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells. J Gastroenterol Hepatol 2016;31:1220-8. [PMID: 26574150 DOI: 10.1111/jgh.13230] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
75 Fiorotto R, Scirpo R, Trauner M, Fabris L, Hoque R, Spirli C, Strazzabosco M. Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice. Gastroenterology. 2011;141:1498-1508, 1508.e1-e5. [PMID: 21712022 DOI: 10.1053/j.gastro.2011.06.052] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 7.7] [Reference Citation Analysis]
76 Wang B, Sun MY, Long AH, Cao HY, Ren S, Bian YQ, Lu X, Gu HT, Liu CH, Liu P. Yin-Chen-Hao-Tang alleviates biliary obstructive cirrhosis in rats by inhibiting biliary epithelial cell proliferation and activation. Pharmacogn Mag 2015;11:417-25. [PMID: 25829784 DOI: 10.4103/0973-1296.153098] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
77 Wang Z, Zhou J, Lin J, Wang Y, Lin Y, Li X. RhGH attenuates ischemia injury of intrahepatic bile ducts relating to liver transplantation. J Surg Res. 2011;171:300-310. [PMID: 20462597 DOI: 10.1016/j.jss.2010.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
78 Spirli C, Okolicsanyi S, Fiorotto R, Fabris L, Cadamuro M, Lecchi S, Tian X, Somlo S, Strazzabosco M. ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice. Gastroenterology. 2010;138:360-371.e7. [PMID: 19766642 DOI: 10.1053/j.gastro.2009.09.005] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 5.2] [Reference Citation Analysis]
79 Fickert P, Pollheimer MJ, Beuers U, Lackner C, Hirschfield G, Housset C, Keitel V, Schramm C, Marschall HU, Karlsen TH, Melum E, Kaser A, Eksteen B, Strazzabosco M, Manns M, Trauner M; International PSC Study Group (IPSCSG). Characterization of animal models for primary sclerosing cholangitis (PSC). J Hepatol. 2014;60:1290-1303. [PMID: 24560657 DOI: 10.1016/j.jhep.2014.02.006] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 9.6] [Reference Citation Analysis]
80 Schaub M, Nussbaum J, Verkade H, Ober EA, Stainier DY, Sakaguchi TF. Mutation of zebrafish Snapc4 is associated with loss of the intrahepatic biliary network. Dev Biol 2012;363:128-37. [PMID: 22222761 DOI: 10.1016/j.ydbio.2011.12.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
81 Fiorotto R, Amenduni M, Mariotti V, Fabris L, Spirli C, Strazzabosco M. Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy. Hepatology 2018;67:972-88. [PMID: 28836688 DOI: 10.1002/hep.29400] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
82 El-Araby HA, Saber MA, Radwan NM, Taie DM, Adawy NM, Sira AM. SOX9 in biliary atresia: New insight for fibrosis progression. Hepatobiliary Pancreat Dis Int 2021;20:154-62. [PMID: 33349604 DOI: 10.1016/j.hbpd.2020.12.007] [Reference Citation Analysis]
83 Peringeth G, Torka P, Wong J, Hernandez-Ilizaliturri FJ. Successful Treatment of Paraneoplastic Cholestasis in Relapsed/Refractory Hodgkin Lymphoma With Bridging Therapy and Checkpoint Blockade. Clin Lymphoma Myeloma Leuk 2020;20:e316-9. [PMID: 32179034 DOI: 10.1016/j.clml.2020.01.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
84 Di Gregorio J, Robuffo I, Spalletta S, Giambuzzi G, De Iuliis V, Toniato E, Martinotti S, Conti P, Flati V. The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders. Front Cell Dev Biol 2020;8:607483. [PMID: 33409282 DOI: 10.3389/fcell.2020.607483] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
85 Ruemmele P, Hofstaedter F, Gelbmann CM. Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 2009;6:287-95. [DOI: 10.1038/nrgastro.2009.46] [Cited by in Crossref: 92] [Cited by in F6Publishing: 70] [Article Influence: 7.1] [Reference Citation Analysis]
86 Kirchner GI, Rümmele P. Update on Sclerosing Cholangitis in Critically Ill Patients. Viszeralmedizin 2015;31:178-84. [PMID: 26468312 DOI: 10.1159/000431031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
87 Jung D, York JP, Wang L, Yang C, Zhang A, Francis HL, Webb P, McKeehan WL, Alpini G, Lesage GD, Moore DD, Xia X. FXR-induced secretion of FGF15/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway. Pflugers Arch 2014;466:1011-9. [PMID: 24068255 DOI: 10.1007/s00424-013-1364-3] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
88 Changho S, Ahmed AA. Neutrophils in biliary atresia. A study on their morphologic distribution and expression of CAP37. Pathology - Research and Practice 2010;206:314-7. [DOI: 10.1016/j.prp.2010.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
89 Fiorotto R, Strazzabosco M. Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota. Cell Mol Gastroenterol Hepatol 2019;8:197-207. [PMID: 31075352 DOI: 10.1016/j.jcmgh.2019.04.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
90 Dasarathy S. Inflammation and liver. JPEN J Parenter Enteral Nutr. 2008;32:660-666. [PMID: 18974249 DOI: 10.1177/0148607108324584] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
91 Fiorotto R, Villani A, Kourtidis A, Scirpo R, Amenduni M, Geibel PJ, Cadamuro M, Spirli C, Anastasiadis PZ, Strazzabosco M. The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity. Hepatology. 2016;64:2118-2134. [PMID: 27629435 DOI: 10.1002/hep.28817] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
92 Dianat N, Dubois-Pot-Schneider H, Steichen C, Desterke C, Leclerc P, Raveux A, Combettes L, Weber A, Corlu A, Dubart-Kupperschmitt A. Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells. Hepatology. 2014;60:700-714. [PMID: 24715669 DOI: 10.1002/hep.27165] [Cited by in Crossref: 127] [Cited by in F6Publishing: 117] [Article Influence: 15.9] [Reference Citation Analysis]
93 Nejak-Bowen K. If It Looks Like a Duct and Acts Like a Duct: On the Role of Reprogrammed Hepatocytes in Cholangiopathies. Gene Expr 2020;20:19-23. [PMID: 31439080 DOI: 10.3727/105221619X15664105014956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
94 Patsenker E, Popov Y, Stickel F, Jonczyk A, Goodman SL, Schuppan D. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. Gastroenterology. 2008;135:660-670. [PMID: 18538673 DOI: 10.1053/j.gastro.2008.04.009] [Cited by in Crossref: 133] [Cited by in F6Publishing: 144] [Article Influence: 9.5] [Reference Citation Analysis]
95 Tomur A, Kanter M, Gurel A, Erboga M. The efficiency of CAPE on retardation of hepatic fibrosis in biliary obstructed rats. J Mol Histol 2011;42:451-8. [PMID: 21822612 DOI: 10.1007/s10735-011-9350-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
96 Dobreva I, Karagyozov P. Drug-induced Bile Duct Injury - A Short Review. Curr Drug Metab 2020;21:256-9. [PMID: 32310045 DOI: 10.2174/1389200221666200420100129] [Reference Citation Analysis]
97 Yska MJ, Buis CI, Monbaliu D, Schuurs TA, Gouw AS, Kahmann ON, Visser DS, Pirenne J, Porte RJ. The role of bile salt toxicity in the pathogenesis of bile duct injury after non-heart-beating porcine liver transplantation. Transplantation. 2008;85:1625-1631. [PMID: 18551070 DOI: 10.1097/tp.0b013e318170f5f7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
98 Glaser S, Francis H, DeMorrow S, LeSage G, Fava G, Marzioni M, Venter J, Alpini G. Heterogeneity of the intrahepatic biliary epithelium. World J Gastroenterol 2006; 12(22): 3523-3536 [PMID: 16773709 DOI: 10.3748/wjg.v12.i22.3523] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
99 Strazzabosco M, Fabris L. The balance between Notch/Wnt signaling regulates progenitor cells’ commitment during liver repair: mystery solved? J Hepatol. 2013;58:181-183. [PMID: 22902547 DOI: 10.1016/j.jhep.2012.08.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
100 Han Y, Glaser S, Meng F, Francis H, Marzioni M, McDaniel K, Alvaro D, Venter J, Carpino G, Onori P, Gaudio E, Alpini G, Franchitto A. Recent advances in the morphological and functional heterogeneity of the biliary epithelium. Exp Biol Med (Maywood) 2013;238:549-65. [PMID: 23856906 DOI: 10.1177/1535370213489926] [Cited by in Crossref: 45] [Cited by in F6Publishing: 91] [Article Influence: 5.0] [Reference Citation Analysis]
101 Zen Y, Hübscher SG, Nakanuma Y. Bile Duct Diseases. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 515-93. [DOI: 10.1016/b978-0-7020-6697-9.00009-1] [Cited by in Crossref: 9] [Article Influence: 2.3] [Reference Citation Analysis]
102 Fabris L, Fiorotto R, Spirli C, Cadamuro M, Mariotti V, Perugorria MJ, Banales JM, Strazzabosco M. Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases. Nat Rev Gastroenterol Hepatol 2019;16:497-511. [PMID: 31165788 DOI: 10.1038/s41575-019-0156-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
103 Fiorotto R, Amenduni M, Mariotti V, Fabris L, Spirli C, Strazzabosco M. Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases. Biochim Biophys Acta Mol Basis Dis 2019;1865:920-8. [PMID: 30264693 DOI: 10.1016/j.bbadis.2018.08.038] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
104 Strazzabosco M, Fabris L. Development of the bile ducts: essentials for the clinical hepatologist. J Hepatol. 2012;56:1159-1170. [PMID: 22245898 DOI: 10.1016/j.jhep.2011.09.022] [Cited by in Crossref: 111] [Cited by in F6Publishing: 95] [Article Influence: 11.1] [Reference Citation Analysis]
105 Spirli C, Mariotti V, Villani A, Fabris L, Fiorotto R, Strazzabosco M. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease. J Hepatol 2017;66:571-80. [PMID: 27826057 DOI: 10.1016/j.jhep.2016.10.032] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
106 Sabbatini ME, Gorelick F, Glaser S. Adenylyl cyclases in the digestive system. Cell Signal 2014;26:1173-81. [PMID: 24521753 DOI: 10.1016/j.cellsig.2014.01.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
107 Morell CM, Fiorotto R, Fabris L, Strazzabosco M. Notch signalling beyond liver development: emerging concepts in liver repair and oncogenesis. Clin Res Hepatol Gastroenterol. 2013;37:447-454. [PMID: 23806629 DOI: 10.1016/j.clinre.2013.05.008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
108 Park SM. The crucial role of cholangiocytes in cholangiopathies. Gut Liver. 2012;6:295-304. [PMID: 22844556 DOI: 10.5009/gnl.2012.6.3.295] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
109 Cadamuro M, Brivio S, Spirli C, Joplin RE, Strazzabosco M, Fabris L. Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma. Int J Mol Sci 2017;18:E149. [PMID: 28098760 DOI: 10.3390/ijms18010149] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]